HeartFlow

History

2023: Raising $215 million in investments

On April 6, 2023, the California company HeartFlow announced a Series F funding round, during which $215 million was raised for development. The money is expected to help meet the growing demand for HeartFlow commercial products in the international market.

Mountain View-based HeartFlow is developing technology to 3D scan hearts and detect its pathologies in 20 minutes. The non-invasive platform uses artificial intelligence to create a personalized three-dimensional organ model. The system is available in,, USA, and Britain To Canada Japan a number of other countries. In addition, HeartFlow provides tools for creating an anatomical map of coronary arteries and other means that help predict heart attack risk. It is noted that the company's solutions are used in more than 725 medical institutions around the world, where approximately 180 thousand patients helped.

HeartFlow provides tools to create anatomical map of coronary arteries

The Series F funding round will be led by Bain Capital Life Sciences with existing investors in Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, U.S. Venture Partners (USVP) and Wellington Management. In addition, the money will be provided by a new participant - Janus Henderson Investors.

Hosting the Series F round, especially in the current market environment, is a strong confirmation of the effectiveness of our technology, our team and the opportunities ahead of us. We appreciate the support of investors, both existing and new, who share HeartFlow's vision to create an advanced standard of care for people at risk of cardiovascular disease, "said John Farquhar, CEO of HeartFlow.[1]

Notes